Companies · Other Health Care

Golo, LLC

WILMINGTON · Other Health Care

Diligence memoA one-page analyst read on Golo, LLC — recommendation, valuation, rhythm, risks.
$4.7M
Total raised · real
4
Rounds
0.1×
Latest step-up
Top 38%
Sector rank · raised
Seed
Latest stage · inferred · Mon Dec 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

Golo, LLC looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.41× the median modeled value of Seed Other Health Care companies in 2013–2015 (251 peers) — value vs value, same stage and era.
  • Within the normal band (141% of peer median) for its niche.
Dormant
  • Last raise 10.5 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Golo, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
14.2 yr record
Peak capital year was 2015 with $3.7M across 3 filings.
Market position
ahead of 63% of Other Health Care peers
Capital scale is ahead of 63% of Other Health Care peers; modeled value is above 70% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2015: $3.7M across 3 filings.
  • Largest single filing was $2.4M on 2015-12-21.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Golo, LLC is one of 5376 Other Health Care companies tracked from WILMINGTON. By capital raised it ranks mid-pack (ahead of 63% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MPre-Seed · 2012-04-10 Raised $1.0M (real) Modeled valuation $31M (est)$1.0M$31MPre-Seed2012Pre-Seed · 2015-05-29 Raised $1.0M (real) Modeled valuation $31M (est)$1.0M$31MPre-Seed2015Seed · 2015-12-21 Raised $2.4M (real) Modeled valuation $61M (est)$2.4M$61MSeed2015Pre-Seed · 2015-12-21 Raised $250K (real) Modeled valuation $7.7M (est)$250K$7.7MPre-Seed2015+$1.0M+$2.4M+$250KCumulative $4.7M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$1.0M · 2012
Pre-Seed extension$1.0M · 2015
Seed$2.4M · 2015
Bridge · Seed-stage$250K · 2015smaller follow-on

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$60.7M
Base estimate est.
$2.1M
Conservative case
$476.4M
Upside case
$12.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $30.8M · 2012-04-102012Pre-Seed · modeled $30.8M · 2015-05-29Seed · modeled $60.7M · 2015-12-21Pre-Seed · modeled $7.7M · 2015-12-212015
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
10.5 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
15 mo
Avg between rounds
$1.3M/yr
Capital velocity
14.2 yr
On record since
2012
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.9× above median
This company$4.7M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.1× of median
This company$250K
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 2.7× above median
This company$60.7M
Sector median$22.1M

Raised more than 63% of sector peers (real $). Modeled value above 70% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #80 of 251.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)RightCare Solutions, Inc. · Seed Raised $8.7M · modeled $99.1M (est)Vios Medical, Inc. · Seed Raised $6.8M · modeled $98.7M (est)HealthEdge Investors DD Holdings, LLC · Seed Raised $4.0M · modeled $97.9M (est)Center at Northridge, LLC · Seed Raised $3.9M · modeled $96.7M (est)Fresenius Medical Care NKDHC, LLC · Seed Raised $3.9M · modeled $96.1M (est)Fresenius Vascular Care Laredo MSO, LLC · Seed Raised $3.9M · modeled $96.1M (est)Health Choice Care, LLC · Seed Raised $3.8M · modeled $94.9M (est)Trio Health Advisory Group, Inc. · Seed Raised $3.8M · modeled $93.3M (est)Okyanos Holdings Co LLC · Seed Raised $3.8M · modeled $92.9M (est)Fresenius Medical Care New Vista, LLC · Seed Raised $3.7M · modeled $91.9M (est)Arcscan Inc · Seed Raised $3.8M · modeled $91.0M (est)IngagePatient, Inc. · Seed Raised $8.3M · modeled $90.9M (est)Golo, LLC (this company) Raised $4.7M · modeled $60.7M (est)Golo, LLC
CompanyStageRaised · realValue · estvs peer med.
RightCare Solutions, Inc.Seed$8.7M$99.1M2.30×
Vios Medical, Inc.Seed$6.8M$98.7M2.29×
HealthEdge Investors DD Holdings, LLCSeed$4.0M$97.9M2.27×
Center at Northridge, LLCSeed$3.9M$96.7M2.25×
Fresenius Medical Care NKDHC, LLCSeed$3.9M$96.1M2.23×
Fresenius Vascular Care Laredo MSO, LLCSeed$3.9M$96.1M2.23×
Health Choice Care, LLCSeed$3.8M$94.9M2.21×
Trio Health Advisory Group, Inc.Seed$3.8M$93.3M2.17×
Okyanos Holdings Co LLCSeed$3.8M$92.9M2.16×
Fresenius Medical Care New Vista, LLCSeed$3.7M$91.9M2.14×
Arcscan IncSeed$3.8M$91.0M2.11×
IngagePatient, Inc.Seed$8.3M$90.9M2.11×
Golo, LLC this companySeed$4.7M$60.7M1.41×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$1.0M2012-04-10$5.6M$30.8M90%
Pre-Seed$1.0M2015-05-29$5.6M$30.8M90%
Seed$2.4M2015-12-21$12.2M$60.7M90%
Pre-Seed$250K2015-12-21$1.4M$7.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$1.0M2012-04-10
    • First recorded raise — entered as Pre-Seed.
  2. Pre-Seed$1.0M2015-05-29
    • Raised again after 38 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  3. Seed$2.4M2015-12-21
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 2.4× larger than the prior — scaling up.
  4. Pre-Seed$250K2015-12-21
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 9.8× smaller than the prior — bridge or down round.
Intelligence
2017 ~Q1
Modeled next raise · ~15mo cadence
$250K
Modeled next size est.range $250K$400K
0.1×
Last step-up
$1.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Bernard Rudnick1 other2015-05
Chris Lundin2012-04
Jennifer Brooks2015-05
Peter Christof Ungermann2015-12
Tony Smith Hastie2015-05
Registry & provenance

Golo, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1548271
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
ClaimReturn, LLCOther Health CareSeed$4.6M$74.4Msame sector · same stage
Rijuven Corp.Other Health CareSeed$4.8M$56.6Msame sector · same stage
AlgoMedica, Inc.Other Health CareSeed$4.6M$65.9Msame sector · same stage
Rise Health, Inc.Other Health CareSeed$4.5M$74.4Msame sector · same stage
Context Matters, Inc.Other Health CareSeed$4.5M$74.4Msame sector · same stage
ExceleraRx Corp.Other Health CareSeed$4.9M$49.6Msame sector · same stage
MedAvante IncOther Health CareSeed$4.9M$56.8Msame sector · same stage
Silverado Southlake, LLCOther Health CareSeed$4.9M$73.9Msame sector · same stage
Frequently asked
How much funding has Golo, LLC raised?
Golo, LLC has raised approximately $4.7M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Golo, LLC's estimated valuation?
Provath's modeled valuation for Golo, LLC is approximately $60.7M (modeled range $2.1M–$476.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Golo, LLC at?
Golo, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Mon Dec 21.
What does Golo, LLC do and where is it based?
Golo, LLC operates in the Other Health Care sector, based in WILMINGTON.
Explore related

See where Golo, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Golo, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.